Sign In
Buy NVS
$148.93
+1.85 (+1.26%)
At Close: Jun 22, 2026
The 91 'Best Dividend Stocks On Earth' For June
10:52pm, Thursday, 27'th May 2021
Kiplinger "insights for investors" online, first offered this list of 91 "Top Dividend Stocks From Around The World" July 13, 2020. Data updated 5/25/21 revealed 13 yields ripe for picking. These Inte
Novartis (NVS) & Molecular Partners Initiate Study for COVID-19
03:47pm, Thursday, 27'th May 2021
Novartis (NVS) initiates study for investigating its novel DARPin therapeutic candidate, ensovibep (MP0420), for the treatment of COVID-19, in collaboration with Molecular Partners.
Novartis, Molecular Partners Initiate Global Trial For COVID-19 Treatment
08:19am, Thursday, 27'th May 2021
Novartis AG (NYSE: NVS) along with Molecular Partners AG (OTC: MLLCF) is kicking off a Phase 2/3 EMPATHY study of DARPin therapeutic candidate, ensovibep (MP0420), to treat COVID-19. The program
Novartis AG (NVS) Presents at Cardiovascular Update Broker Conference Call - (Transcript)
07:47pm, Tuesday, 18'th May 2021
Novartis AG (NVS) Presents at Cardiovascular Update Broker Conference Call - (Transcript)
Supreme Court Rebuffs Novartis Appeal Over Amgen's Arthritis Drug Enbrel: Report
04:37pm, Monday, 17'th May 2021
The Supreme Court turned away a petition from Sandoz seeking to challenge two Amgen Inc (NASDAQ: AMGN) patents related to rheumatoid arthritis drug Enbrel, thus blocking Novartis AG's (NYSE: NVS
3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes
11:16am, Monday, 03'rd May 2021
3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes
3 High-Yield Stocks for Dividend Investors
09:47am, Monday, 03'rd May 2021
The following three stocks may be of interest to dividend investors, as they are offering much higher dividend yields than the S&P 500 Index. The benchmark index's dividend yields 1.38% as of Friday,
NVS Stock: From $85.24 To $86.10 (1.01% Increase) Pre-Market Explanation
09:02am, Monday, 03'rd May 2021
The stock price of Novartis AG (NYSE: NVS) increased by 1.01% as it went from $85.24 to $86.10 pre-market. This is why it happened.
Novartis' Beovu Non-Inferior To Aflibercept In Phase 3 Diabetic Macular Edema Study
07:34am, Monday, 03'rd May 2021
Novartis AG (NYSE: NVS) has reported that its Beovu (brolucizumab) drug met primary endpoints in Phase 3 KESTREL and KITE trials conducted in diabetic macular edema (DME) patients. According t
ARK Genomic Revolution ETF: Value Realization Will Take Time
04:46am, Monday, 03'rd May 2021
ARK Genomic Revolution ETF: Value Realization Will Take Time
The Eaton Vance Fund sells Novartis, Pfizer
01:03pm, Friday, 30'th Apr 2021
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) sold shares of the following stocks during the first quarter of 2021, which ended on March 31.
Update: 91 'Top Dividend Stocks On Earth' For May
01:18pm, Wednesday, 28'th Apr 2021
Kiplinger "insights for investors" online first offered this list of 91 "Top Dividend Stocks From Around The World" July 13, 2020. Data updated 4/26/21 flagged 13 yields ripe with upside. These Intern
Novartis Continues To Hurt From Ophthalmology And Oncology, Sandoz Drags As Well
09:09am, Wednesday, 28'th Apr 2021
Novartis Continues To Hurt From Ophthalmology And Oncology, Sandoz Drags As Well
Novartis (NVS) Q1 Earnings & Sales Miss Estimates on COVID-19 Woes
01:32pm, Tuesday, 27'th Apr 2021
Novartis (NVS) reports lower-than-expected first-quarter results, as the pandemic continues to negatively impact sales.
Why Novartis Missed Wall Street Q1 Estimates
11:53am, Tuesday, 27'th Apr 2021
It was partially because of COVID-19.
